Phagelux utilizes phages, lysins and other biologics and related delivery technologies to create antibacterial products and solutions. Phagelux is headquartered in Shanghai and has a cumulative of four research laboratories worldwide and also manufacturing facilities in both the United States and China. Phagelux has both HumanHealth and AgriHealth divisions (crop sciences, animal health and food safety). The HumanHealth Division has 5 products under development. The AgriHealth division has 3 products on the market with another 9 under development.
Phagelux aims to be a leading global anti-infectives company by utilizing various biological solutions to address bacterial problems across multiple industries, particularly targeting antibiotic resistant strains of bacteria.
Nanjing R&D Center